West Pharmaceutical Services Share Holder Equity 2010-2024 | WST

West Pharmaceutical Services share holder equity from 2010 to 2024. Share holder equity can be defined as the sum of preferred and common equity items
  • West Pharmaceutical Services share holder equity for the quarter ending September 30, 2024 was $2.752B, a 4.05% decline year-over-year.
  • West Pharmaceutical Services share holder equity for 2023 was $2.881B, a 7.3% increase from 2022.
  • West Pharmaceutical Services share holder equity for 2022 was $2.685B, a 14.97% increase from 2021.
  • West Pharmaceutical Services share holder equity for 2021 was $2.335B, a 25.93% increase from 2020.
West Pharmaceutical Services Annual Share Holder Equity
(Millions of US $)
2023 $2,881
2022 $2,685
2021 $2,335
2020 $1,855
2019 $1,573
2018 $1,396
2017 $1,280
2016 $1,118
2015 $1,024
2014 $957
2013 $906
2012 $729
2011 $655
2010 $626
2009 $579
West Pharmaceutical Services Quarterly Share Holder Equity
(Millions of US $)
2024-09-30 $2,752
2024-06-30 $2,577
2024-03-31 $2,681
2023-12-31 $2,881
2023-09-30 $2,868
2023-06-30 $2,747
2023-03-31 $2,776
2022-12-31 $2,685
2022-09-30 $2,471
2022-06-30 $2,424
2022-03-31 $2,326
2021-12-31 $2,335
2021-09-30 $2,202
2021-06-30 $2,033
2021-03-31 $1,829
2020-12-31 $1,855
2020-09-30 $1,719
2020-06-30 $1,606
2020-03-31 $1,490
2019-12-31 $1,573
2019-09-30 $1,488
2019-06-30 $1,445
2019-03-31 $1,370
2018-12-31 $1,396
2018-09-30 $1,352
2018-06-30 $1,282
2018-03-31 $1,305
2017-12-31 $1,280
2017-09-30 $1,317
2017-06-30 $1,242
2017-03-31 $1,169
2016-12-31 $1,118
2016-09-30 $1,142
2016-06-30 $1,109
2016-03-31 $1,074
2015-12-31 $1,024
2015-09-30 $995
2015-06-30 $989
2015-03-31 $941
2014-12-31 $957
2014-09-30 $970
2014-06-30 $973
2014-03-31 $935
2013-12-31 $906
2013-09-30 $837
2013-06-30 $784
2013-03-31 $746
2012-12-31 $729
2012-09-30 $717
2012-06-30 $680
2012-03-31 $695
2011-12-31 $655
2011-09-30 $691
2011-06-30 $696
2011-03-31 $663
2010-12-31 $626
2010-09-30 $632
2010-06-30 $571
2010-03-31 $580
2009-12-31 $579
2009-09-30 $566
2009-06-30 $533
2009-03-31 $489
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $22.024B $2.950B
West Pharmaceutical Services Inc. is a leading global manufacturer with respect to design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. The Exton, PA-based company designs and produces these medical products in the Americas, Europe, the Middle East, Africa and the Asia Pacific. Its primary objective is to deliver quality products that cater to the exact product specifications and quality standards that customers expect and need. West Pharmaceutical operates through two segments: Proprietary Products and Contract-Manufactured Products.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $78.151B 21.33
Becton Dickinson (BDX) United States $64.352B 16.92
Cardinal Health (CAH) United States $28.637B 15.53
Labcorp (LH) United States $19.758B 16.38
Cooper (COO) United States $19.726B 28.08
Align Technology (ALGN) United States $16.616B 31.80
Henry Schein (HSIC) United States $9.331B 17.78
Merit Medical Systems (MMSI) United States $6.102B 31.16
DENTSPLY SIRONA (XRAY) United States $3.753B 10.20
CONMED (CNMD) United States $2.216B 18.49
Patterson (PDCO) United States $1.799B 9.49
STAAR Surgical (STAA) United States $1.288B 47.53
Lifevantage (LFVN) United States $0.170B 22.60
Pro-Dex (PDEX) United States $0.147B 29.36